Dynamic circulating tumor DNA quantificaton for the individualization of non-small-cell lung cancer patients treatment

BACKGROUND: Liquid biopsy has evolved from being a promising line to becoming a validated approach for biomarker testing. However, its utility for individualization of therapy has been scarcely reported. In this study, we show how monitoring levels of EGFR mutation in plasma can be useful for the in...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncotarget
Glavni autori: Provencio, Mariano, Torrente, María, Calvo, Virgina, Gutiérrez, Lourdes, Pérez-Callejo, David, Pérez-Barrios, Clara, Barquín, Miguel, Royuela, Ana, Rodriguez-Alfonso, Begoña, Sotelo, Miguel, Cruz-Bermúdez, Juan Luis, Mendez, Miriam, Cruz-Bermúdez, Alberto, Romero, Atocha
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2017
Teme:
Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5601139/
https://ncbi.nlm.nih.gov/pubmed/28947971
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.20016
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items